We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

15 hedge funds and large institutions have $3.49M invested in Edesa Biotech in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,152% more capital invested

Capital invested by funds: $279K → $3.49M (+$3.21M)

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$2.96M
2
VKH
Virtu KCG Holdings
New York
+$59.8K
3
UBS Group
UBS Group
Switzerland
+$7.21K
4
Bank of America
Bank of America
North Carolina
+$1.03K
5
Morgan Stanley
Morgan Stanley
New York
+$1.03K

Top Sellers

Rank Fund Capital Flow
1
AIG
American International Group
New York
-$209K
2
LTFS
Ladenburg Thalmann Financial Services
Florida
-$8.24K
3
Citigroup
Citigroup
New York
-$3K
4
Deutsche Bank
Deutsche Bank
Germany
-$3K
5
TRCT
Tower Research Capital (TRC)
New York
-$2.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$3.22M +$2.96M +2,870 New
AG
2
Advisor Group
Arizona
$155K +$143K +139 New
VKH
3
Virtu KCG Holdings
New York
$65K +$59.8K +58 New
UBS Group
4
UBS Group
Switzerland
$16K +$7.21K +7 +88%
Creative Planning
5
Creative Planning
Kansas
$7K – – –
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$4K -$1.03K -1 -25%
WP
7
WealthPLAN Partners
Nebraska
$3.82K +$3.09K +3 New
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$3K -$8.24K -8 -80%
TRCT
9
Tower Research Capital (TRC)
New York
$3K -$2.06K -2 -40%
ASN
10
Advisory Services Network
Georgia
$3K – – –
Bank of America
11
Bank of America
North Carolina
$3K +$1.03K +1 +50%
EDRH
12
Edmond de Rothschild Holding
Switzerland
$2K – – –
EDRS
13
Edmond de Rothschild (Suisse)
Switzerland
$2K – – –
WAM
14
Wealthspire Advisors (Maryland)
Maryland
$2K – – –
Morgan Stanley
15
Morgan Stanley
New York
$2K +$1.03K +1 +100%
AIG
16
American International Group
New York
– -$209K -147 Closed
Citigroup
17
Citigroup
New York
– -$3K -2 Closed
Deutsche Bank
18
Deutsche Bank
Germany
– -$3K -2 Closed
Wells Fargo
19
Wells Fargo
California
– -$2K -1 Closed

EDSA Hedge Fund Activity: Q2 2016 in Review

15 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2016, worth a combined $3.49M — up 1,152% from $279K a quarter earlier.

Fund positioning in EDSA was balanced in Q2 2016: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $2.96M. The largest seller was American International Group, exiting entirely with an estimated $209K sold.

  • 15 institutional investors held Edesa Biotech (EDSA) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $3.49M of Edesa Biotech stock for Q2 2016, up 1,152% quarter-over-quarter.
  • 4 funds opened new Edesa Biotech positions in Q2 2016 and 4 closed out, a net change of 0 holders.
  • The largest Edesa Biotech buyer in Q2 2016 was Anson Funds Management, an estimated $2.96M added.
  • The largest Edesa Biotech seller in Q2 2016 was American International Group, an estimated $209K sold.

Based on aggregated 13F filings for Q2 2016.